Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study
- Author
- JOHNSON, Julie A1 2 ; BOERWINKLE, Eric3 ; SCHWARTZ, Gary5 ; TURNER, Stephen T5 ; ZINEH, Issam1 2 ; CHAPMAN, Arlene B4 ; BAILEY, Kent5 ; COOPER-DEHOFF, Rhonda M1 2 ; GUMS, John1 2 ; WHIT CURRY, R2 ; YAN GONG1 ; BEITELSHEES, Amber L1
[1] University of Florida College of Pharmacy and Center for Pharmacogenomics, Gainesville, FL, United States
[2] University of Florida College of Medicine, Gainesville, FL, United States
[3] University of Texas at Houston Center for Human Genetics, Houston, TX, United States
[4] Emory University School of Medicine, Atlanta, GA, United States
[5] Mayo Clinic College of Medicine, Rochester, MN, United States - Source
The American heart journal. 2009, Vol 157, Num 3, pp 442-449, 8 p ; ref : 19 ref
- CODEN
- AHJOA2
- ISSN
- 0002-8703
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Mosby, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antihypertenseur Appareil circulatoire Cardiologie Conception Evaluation Pathologie de l'appareil circulatoire Réponse
- Keyword (en)
- Antihypertensive agent Circulatory system Cardiology Design Evaluation Cardiovascular disease Response
- Keyword (es)
- Antihipertensivo Aparato circulatorio Cardiología Diseño Evaluación Aparato circulatorio patología Respuesta
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21234916
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.ahj.2008.11.018 
https://dx.doi.org/10.1016/j.ahj.2008.11.018
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2008.11.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"157\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"442\";s:8:\"\u0000*\u0000epage\";s:3:\"449\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"JOHNSON\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Julie A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BOERWINKLE, Eric\";i:1;s:14:\"SCHWARTZ, Gary\";i:2;s:17:\"TURNER, Stephen T\";i:3;s:12:\"ZINEH, Issam\";i:4;s:17:\"CHAPMAN, Arlene B\";i:5;s:12:\"BAILEY, Kent\";i:6;s:23:\"COOPER-DEHOFF, Rhonda M\";i:7;s:10:\"GUMS, John\";i:8;s:13:\"WHIT CURRY, R\";i:9;s:8:\"YAN GONG\";i:10;s:20:\"BEITELSHEES, Amber L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:5:\"Mosby\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2008.11.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"157\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"442\";s:8:\"\u0000*\u0000epage\";s:3:\"449\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"JOHNSON\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Julie A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BOERWINKLE, Eric\";i:1;s:14:\"SCHWARTZ, Gary\";i:2;s:17:\"TURNER, Stephen T\";i:3;s:12:\"ZINEH, Issam\";i:4;s:17:\"CHAPMAN, Arlene B\";i:5;s:12:\"BAILEY, Kent\";i:6;s:23:\"COOPER-DEHOFF, Rhonda M\";i:7;s:10:\"GUMS, John\";i:8;s:13:\"WHIT CURRY, R\";i:9;s:8:\"YAN GONG\";i:10;s:20:\"BEITELSHEES, Amber L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:5:\"Mosby\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2008.11.018\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2008.11.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"157\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"442\";s:8:\"\u0000*\u0000epage\";s:3:\"449\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"JOHNSON\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Julie A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BOERWINKLE, Eric\";i:1;s:14:\"SCHWARTZ, Gary\";i:2;s:17:\"TURNER, Stephen T\";i:3;s:12:\"ZINEH, Issam\";i:4;s:17:\"CHAPMAN, Arlene B\";i:5;s:12:\"BAILEY, Kent\";i:6;s:23:\"COOPER-DEHOFF, Rhonda M\";i:7;s:10:\"GUMS, John\";i:8;s:13:\"WHIT CURRY, R\";i:9;s:8:\"YAN GONG\";i:10;s:20:\"BEITELSHEES, Amber L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:5:\"Mosby\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2008.11.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"157\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"442\";s:8:\"\u0000*\u0000epage\";s:3:\"449\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"JOHNSON\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Julie A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BOERWINKLE, Eric\";i:1;s:14:\"SCHWARTZ, Gary\";i:2;s:17:\"TURNER, Stephen T\";i:3;s:12:\"ZINEH, Issam\";i:4;s:17:\"CHAPMAN, Arlene B\";i:5;s:12:\"BAILEY, Kent\";i:6;s:23:\"COOPER-DEHOFF, Rhonda M\";i:7;s:10:\"GUMS, John\";i:8;s:13:\"WHIT CURRY, R\";i:9;s:8:\"YAN GONG\";i:10;s:20:\"BEITELSHEES, Amber L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:5:\"Mosby\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1016\/j.ahj.2008.11.018\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:9:\"\u0000*\u0000jtitle\";s:26:\"The American heart journal\";s:9:\"\u0000*\u0000stitle\";s:11:\"Am. heart j\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:3:\"157\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"442\";s:8:\"\u0000*\u0000epage\";s:3:\"449\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0002-8703\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"JOHNSON\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Julie A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:16:\"BOERWINKLE, Eric\";i:1;s:14:\"SCHWARTZ, Gary\";i:2;s:17:\"TURNER, Stephen T\";i:3;s:12:\"ZINEH, Issam\";i:4;s:17:\"CHAPMAN, Arlene B\";i:5;s:12:\"BAILEY, Kent\";i:6;s:23:\"COOPER-DEHOFF, Rhonda M\";i:7;s:10:\"GUMS, John\";i:8;s:13:\"WHIT CURRY, R\";i:9;s:8:\"YAN GONG\";i:10;s:20:\"BEITELSHEES, Amber L\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AHJOA2\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Pharmacogenomics of antihypertensive drugs : Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:5:\"Mosby\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
